MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acvd.2026.04.006

Медицинская библиотека · Archives of cardiovascular diseases · 2026

Feasibility and safety of "fast-track" protocol after TAVI.

Rahmani Sami, Polo Julien, Boyer Jeremy, Roussel Thomas, Morera Pierre, Jaussaud Nicolas, Porto Alizée, Collart Frédéric, Deharo Pierre, Cuisset Thomas

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Transcatheter aortic valve implantation is the standard treatment for symptomatic severe aortic stenosis. Advances in technology and minimally invasive techniques have made early discharge following transcatheter aortic valve implantation a feasible and safe option, optimizing hospital resource utilization without compromising care quality.

AIM: To evaluate the feasibility and safety of early discharge ("fast-track") following transcatheter aortic valve implantation in a single high-volume centre.

METHODS

This single-centre retrospective study included consecutive patients undergoing transcatheter aortic valve implantation (TAVI) for symptomatic severe aortic stenosis between April 2022 and December 2023. Patients were stratified into FT- (ineligible), FT+/+ (next day discharge achieved), and FT+/- (early discharge failed) groups. The primary endpoint was a 3-month composite safety outcome.

RESULTS

Between April 2022 and December 2023, 506 patients aged>18 years with severe symptomatic aortic stenosis underwent transcatheter aortic valve implantation at the University Hospital of Marseille Timone; of these, 479 patients were included in the analysis. Overall, 80.8% (n=409; 95% confidence interval 77.2-84.0%) of the total patient population were eligible for fast track (FT+). The primary reason for ineligibility (FT-) was the presence of complete right bundle branch block (49.6%, n=54; 95% confidence interval 40.1-59.2%). Among FT+ patients, 69.9% (n=286; 95% confidence interval 65.3-74.1%) were discharged the next day (FT+/+); the early discharge strategy failed in 30.1% (n=123) (FT+/-). Prolonged rhythm monitoring as a result of acquired conduction disorders delayed discharge in 55.9% (n=76; 95% confidence interval 47.0-64.3%) of FT+/- cases. High-grade conduction disorders necessitated a mean wait of 4.1 days for pacemaker implantation. At 3-month follow-up, cardiovascular events occurred in 4.4% (n=12/275) of FT+/+ patients, 6.9% (n=8/116) of FT+/- patients and 11.4% (n=10/88) of FT- patients (P=0.06).

CONCLUSIONS

Next-day discharge after transcatheter aortic valve implantation was feasible and safe for 69.9% of eligible patients (representing 56.5% of the overall cohort). Eligibility for the fast track protocol was achieved in 80.8% of patients. Conduction disturbances and vascular complications remain key obstacles leading to prolonged hospital stays and requiring optimization.

Для цитирования: Rahmani Sami, Polo Julien, Boyer Jeremy, Roussel Thomas, Morera Pierre, Jaussaud Nicolas, Porto Alizée, Collart Frédéric, Deharo Pierre, Cuisset Thomas. Feasibility and safety of "fast-track" protocol after TAVI.. Archives of cardiovascular diseases. 2026. DOI: 10.1016/j.acvd.2026.04.006.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.